Labs in Court: Two EKRA-Related Cases and Some Usual Suspects
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
From - G2 Compliance Advisor
The Office of Inspector General's Compliance Program Guidance for Clinical Laboratories includes among its seven elements for a comprehensive compliance program…
From - G2 Compliance Advisor
While labs may draft a comprehensive compliance plan and policies and procedures, those policies, procedures and plan can be a liability if…
From - G2 Compliance Advisor
Hiring and firing staff are difficult challenges. While there are many factors to consider in making either decision, compliance should be front of mind in…
From - G2 Compliance Advisor
Labs need to use the power of data to make compliance programs more focused, efficient and successful. Take a lesson from…